HomeARTV • NASDAQ
Artiva Biotherapeutics Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 0.00 | -100.00% |
Operating expense | 18.27M | 27.56% |
Net income | -16.10M | -34.15% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -17.65M | -55.18% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 185.43M | 140.91% |
Total assets | 209.58M | 99.38% |
Total liabilities | 22.94M | -54.77% |
Total equity | 186.64M | — |
Shares outstanding | 24.36M | — |
Price to book | 0.37 | — |
Return on assets | -20.99% | — |
Return on capital | -21.90% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -16.10M | -34.15% |
Cash from operations | -14.65M | -37.24% |
Cash from investing | -966.00K | 63.79% |
Cash from financing | -30.00K | -103.12% |
Net change in cash | -15.65M | -26.37% |
Free cash flow | -9.00M | — |
Previous close
$2.86
Day range
$2.55 - $2.80
Year range
$2.55 - $17.31
Market cap
62.61M USD
Avg Volume
116.30K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2019
Website
Employees
89
